Annual Secretarial Compliance Report for the financial year ended March 31, 2025
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Ltd has submitted its Annual Secretarial Compliance Report for FY ended March 31, 2025, as required under SEBI's Listing Regulations. The report was prepared by Parikh & Associates, Practicing Company Secretaries. The company received a clean compliance report with NIL observations or deviations across all applicable SEBI regulations, including insider trading, related party transactions, and disclosure norms. All 13 specific compliance areas were marked as compliant (YES) or not applicable (NA). No actions were taken by SEBI or stock exchanges against the company, its promoters, or directors during the year.
This is a routine annual compliance filing confirming that Pfizer Ltd has fully met SEBI's listing and disclosure requirements for FY25 with no penalties or non-compliance issues. It reinforces the company's strong corporate governance track record but is unlikely to have any material effect on the stock price.